Veracyte reported $58.35M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US USD 173.07M 13.35M
Agilent A:US USD 1.86B 41M
Anika Therapeutics ANIK:US USD 26.35M 3.08M
Arrowhead Research ARWR:US USD 128.21M 10.64M
Biocept BIOC:US USD 7.15M 2.46M
Bruker BRKR:US USD 864.6M 46.2M
Exact Sciences EXAS:US USD 423.68M 19.65M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Illumina ILMN:US USD 2.67B 212M
Immunogen IMGN:US USD 103.64M 16.57M
Intrexon XON:US USD 104.86M 74.96M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Laboratory Of America LH:US USD 2.52B 120.6M
Ligand Pharmaceuticals LGND:US USD 135.24M 32.61M
Myriad Genetics MYGN:US USD 129.1M 9.4M
Rigel Pharmaceuticals RIGL:US USD 47.26M 7.69M
Sangamo Biosciences SGMO:US USD 122.36M 2.37M
Sonic Healthcare SHL:AU AUD 2.08B 86.85M
Thermo Fisher Scientific TMO:US USD 11.12B 121M
Veracyte VCYT:US USD 58.35M 993K
Waters WAT:US USD 1.54B 798.06M